CHICAGO – To the typical attendee of the American Society of Clinical Oncology (ASCO) annual meeting last week, a shortage of clinical data would not appear to be an obvious or pressing problem. Attending the meeting usually means deciding, at any given moment, which two or three interesting presentations to forego for an even more interesting presentation.